Li Siyu, Zhu Kaili, Xia Chao, Yang Ling, Duan Peibei
School of Nursing, Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China.
Department of General Surgery, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China.
Semin Oncol Nurs. 2025 Feb;41(1):151805. doi: 10.1016/j.soncn.2024.151805. Epub 2025 Jan 9.
To develop temporal symptom networks at three postoperative chemotherapy time points and investigate the longitudinal relationships between 18 symptoms in patients with gastric cancer undergoing postoperative chemotherapy in China.
Symptom prevalence and severity were measured using the M. D. Anderson Symptom Inventory (MDASI) and Gastrointestinal Cancer Module of the MDASI (MDASI-GI) at T1, T2, and T3 on the day after the first, third, and sixth chemotherapy sessions, respectively. Cross-lagged panel network (CLPN) models were employed to examine the temporal dynamics of the 18 symptoms and their interrelationships.
In total, 379 participants were included. Dry mouth had the highest out-prediction (r = 0.101) and out-strength (r = 0.863) values during T1→T2. The strongest direct effect was observed for the change in taste → lack of appetite (β = 0.38) during T2→T3. Feeling bloated had the highest values for out-strength (r = 0.910), out-prediction (r = 0.215), and bridge strength (r = 1.010) during the T2→T3 period. The two CLPNs showed medium to high stability based on the centrality stability coefficients of out-strength and in-strength.
Lack of appetite can be improved during chemotherapy by managing vomiting and taste changes. Attention should be paid to the dry mouth and feeling bloated, as they are the strongest predictors in the early and middle stages of treatment.
Understanding the relationship between symptoms during chemotherapy in patients with postoperative gastric cancer can help clinicians identify targets for intervention at different times.
构建三个术后化疗时间点的症状时间网络,并研究中国接受术后化疗的胃癌患者18种症状之间的纵向关系。
分别在第一次、第三次和第六次化疗后的第1天(T1、T2和T3),使用MD安德森症状问卷(MDASI)和MDASI的胃肠道癌症模块(MDASI-GI)测量症状发生率和严重程度。采用交叉滞后面板网络(CLPN)模型来检验18种症状的时间动态及其相互关系。
共纳入379名参与者。口干在T1→T2期间具有最高的外预测值(r = 0.101)和外强度值(r = 0.863)。在T2→T3期间,味觉变化→食欲不振的直接效应最强(β = 0.38)。在T2→T3期间,腹胀的外强度值(r = 0.910)、外预测值(r = 0.215)和桥接强度值(r = 1.010)最高。基于外强度和内强度的中心性稳定系数,两个CLPN显示出中等到高度的稳定性。
在化疗期间,通过控制呕吐和味觉变化可以改善食欲不振。应关注口干和腹胀,因为它们是治疗早期和中期最强的预测因素。
了解术后胃癌患者化疗期间症状之间的关系有助于临床医生确定不同时间的干预靶点。